Alembic Pharma gets USFDA EIR for Jarod facility
Vadodara: Alembic Pharma has announced that the Company has received an Establishment Inspection Report (EIR) with classification as "Voluntary Action Indicated (VAI)" from the US Food and Drug Administration (USFDA) for the inspection carried out at the Company's Solid Oral Formulation Facility (F-4) at Jarod, Vadodara.
The inspection was conducted from 14th November, 2024 to 22nd November, 2024.
Read also: Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole
Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
